.

Make Better Decisions

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Moodys
AstraZeneca
Citi
Deloitte
Baxter
Merck
QuintilesIMS
US Army
Novartis
US Department of Justice

Generated: November 24, 2017

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: fulvestrant

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Astrazeneca
FASLODEX
fulvestrant
INJECTABLE;INTRAMUSCULAR021344NDAAstraZeneca Pharmaceuticals LP0310-0720-102 SYRINGE, GLASS in 1 CARTON (0310-0720-10) > 5 mL in 1 SYRINGE, GLASS
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Julphar
Fuji
Deloitte
Queensland Health
Boehringer Ingelheim
Cantor Fitzgerald
Colorcon
Argus Health
Cipla

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot